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A feedback loop between dipeptide-repeat
protein, TDP-43 and karyopherin-a mediates
C9orf72-related neurodegeneration
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Accumulation and aggregation of TDP-43 is a major pathological hallmark of amyotrophic lateral sclerosis and frontotemporal
dementia. TDP-43 inclusions also characterize patients with GGGGCC (G4C2) hexanucleotide repeat expansion in C9orf72 that
causes the most common genetic form of amyotrophic lateral sclerosis and frontotemporal dementia (C9ALS/FTD). Functional
studies in cell and animal models have identiﬁed pathogenic mechanisms including repeat-induced RNA toxicity and accumulation
of G4C2-derived dipeptide-repeat proteins. The role of TDP-43 dysfunction in C9ALS/FTD, however, remains elusive. We found
G4C2-derived dipeptide-repeat protein but not G4C2-RNA accumulation caused TDP-43 proteinopathy that triggered onset and
progression of disease in Drosophila models of C9ALS/FTD. Timing and extent of TDP-43 dysfunction was dependent on levels
and identity of dipeptide-repeat proteins produced, with poly-GR causing early and poly-GA/poly-GP causing late onset of disease.
Accumulating cytosolic, but not insoluble aggregated TDP-43 caused karyopherin-a2/4 (KPNA2/4) pathology, increased levels of
dipeptide-repeat proteins and enhanced G4C2-related toxicity. Comparable KPNA4 pathology was observed in both sporadic
frontotemporal dementia and C9ALS/FTD patient brains characterized by its nuclear depletion and cytosolic accumulation, irre-
spective of TDP-43 or dipeptide-repeat protein aggregates. These ﬁndings identify a vicious feedback cycle for dipeptide-repeat
protein-mediated TDP-43 and subsequent KPNA pathology, which becomes self-sufﬁcient of the initiating trigger and causes
C9-related neurodegeneration.
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Introduction
Amyotrophic lateral sclerosis (ALS) and frontotemporal de-
mentia (FTD) are devastating neurodegenerative diseases for
which no cure is available (Van Langenhove et al., 2012; Ling
et al., 2013). Genetic evidence suggests that both diseases form
part of a clinical spectrum, most prominently underpinned by
a large GGGGCC (G4C2) expansion in intron 1 of chromo-
some 9 open reading frame 72 (C9orf72) (DeJesus-Hernandez
et al., 2011; Renton et al., 2011) that is the most common
cause of ALS and FTD (C9ALS/FTD) (Stepto et al., 2014;
Rohrer et al., 2015). In addition to genetic evidence, protein-
aceous inclusions of TAR DNA-binding protein 43 (TDP-43,
encoded by TARDBP) are a histopathological hallmark of
97% of ALS and 45% of FTD cases (Ling et al., 2013).
TDP-43 is an RNA binding protein with two RNA recog-
nition motifs (RRMs), a nuclear localization (NLS) and nu-
clear export signal, and a C-terminal low complexity domain
with prion-like properties that harbours most of the muta-
tions associated with familial forms of ALS and FTD (Lee
et al., 2011). TDP-43 shuttles between the nucleus and cyto-
plasm where it functions in mRNA stability, translation and
transport (Lee et al., 2011; Ederle and Dormann, 2017).
Imbalance of this process leads to cytoplasmic accumulation
and in turn nuclear depletion of TDP-43 and assembly into
aggregates of phosphorylated and ubiquitinated C-terminal
fragments that characterize the progressive and end stages of
disease (Arai et al., 2006; Neumann et al., 2006).
TDP-43 proteinopathy is associated with the majority of
C9ALS/FTD cases that are also characterized by RNA foci
of G4C2 hexanucleotide repeats and sequestered RNA
binding proteins (Haeusler et al., 2016), and inclusions of
dipeptide-repeat proteins (DPRs) that accumulate through
repeat-associated non-ATG (RAN) translation (Ash et al.,
2013; Mori et al., 2014). RAN translation from both sense
and anti-sense G4C2 RNA can lead to poly-glycine–alanine
(GA), poly-proline–alanine (PA), poly-glycine–proline (GP),
poly-glycine–arginine (GR) and poly-proline–arginine (PR)
proteins (Mori et al., 2014). Functional studies in cell and
animal models have identiﬁed pathogenic gain-of-function
mechanisms including repeat-induced RNA toxicity and ac-
cumulation of DPRs (Mizielinska et al., 2014; Wen et al.,
2014; Chew et al., 2015), with recent evidence suggesting
that both cause defective nucleocytoplasmic transport
(NCT) and nuclear pore complex (NPC) deﬁcits that even-
tually lead to age-related neurodegeneration (Freibaum
et al., 2015; Jovicic et al., 2015; Zhang et al., 2015;
Boeynaems et al., 2016, 2017; Lee et al., 2016).
Importantly, comparable NCT and NPC deﬁcits were
also reported most recently in models of TDP-43 aggrega-
tion (Chou et al., 2018).
These ﬁndings suggest that G4C2/DPR-mediated NCT and/
or NPC defects trigger disease formation but raise the question
whether TDP-43 aggregation is a cause or consequence of it.
Moreover, unlike TDP-43 pathology, neither RNA foci nor
DPR distribution spatially correlate with clinical phenotype
and neurodegeneration, except for poly-GR (Saberi et al.,
2018), which together with poly-PR has been shown to be
the most toxic DPR species (Mizielinska et al., 2014). Several
murine models revealed RNA foci and DPRs develop early
but are not sufﬁcient to drive neurodegeneration in the ab-
sence of TDP-43 pathology (O’Rourke et al., 2015; Peters
et al., 2015), whereas neurodegeneration was observed in con-
junction with TDP-43 pathology (Chew et al., 2015; Liu et al.,
2016). Interestingly, in one of these models TDP-43 aggrega-
tion occurred after the formation of both DPRs and RNA foci
(Liu et al., 2016). Furthermore, post-mortem analyses of
C9ALS/FTD patients who died early (but of other causes),
revealed only abundant DPR pathology, further indicating
DPR pathology precedes that of TDP-43 (Proudfoot et al.,
2014; Baborie et al., 2015; Vatsavayai et al., 2016).
Collectively, these data indicate that G4C2 RNA and/or
DPRs act as initiating stressors causing the cytoplasmic mis-
localization, aggregation and subsequent dysfunction of TDP-
43 that mediates C9-related neurodegeneration, likely via
NCT and/or NPC deﬁcits.
Here we identify a vicious feedback loop that mediates
C9ORF72-related neurodegeneration. Using novel in vivo
Drosophila models of C9ALS/FTD and TDP-43 pathology,
we ﬁrst show that accumulation of G4C2-derived DPRs
causes cytoplasmic mislocalization and accumulation of
TDP-43. This in turn leads to nuclear depletion of karyo-
pherin-a (KPNAs) resulting in a vicious cycle of increasing
TDP-43 and KPNA mislocalization and dysfunction, which
is crucially also observed in C9ALS/FTD and sporadic FTD
post-mortem brain tissue.
Materials and methods
For detailed materials and methods, please see the online
Supplementary material.
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Fly stocks and husbandry
Fly stocks were maintained at 25C on standard cornmeal
food, unless for ageing experiments where ﬂies were main-
tained on 15% sugar/yeast medium. Strains used were
Oregon R; w1118; Actin-Gal4; GMR-Gal4; ElavC155-Gal4;
ElavC155;UAS-mCD8-GFP; Gal80ts; Fkh-Gal4; UAS-
mCD8::GFP; UAS-hTDP-43; UAS-Q331K-TDP-43 (Elden
et al., 2010); UAS- RRM1-TDP-43 (Ihara et al., 2013);
and gTBPH.
Generation of transgenic flies
The following UAS-attB constructs were generated: UAS-DsRed2,
UAS-DsRed2-(G4C2)8A,UAS-DsRed2-(G4C2)32, UAS-DsRed2-
(G4C2)56, UAS-DsRed2-(G4C2)64, UAS-DsRed2-(G4C2)128B,
UAS-DsRed2-(G4C2)8B, UAS-DsRed2-(G4C2)38, UAS-GA8,
UAS-GA64, UAS-GR8, UAS-GR64, UAS-PR8, UAS-PR64,
UAS-PA8, UAS-PA64. G4C2 constructs were established that
contained DsRed2 upstream of either (G4C2)8, (G4C2)38 or
(G4C2)56. To generate plasmids containing longer repeat lengths,
a further plasmid containing (G4C2)4 repeats within the 30 UTR
was generated. Two copies of this G4C2 plasmid were then dif-
ferentially digested such that subsequent ligation created a plasmid
containing a doubled G4C2 repeat sequence. This strategy was
used to generate plasmids containing 8, 16, 32, 64 and 128 G4C2
repeats. The presence and size of G4C2 DNA within the ﬂy
genome was conﬁrmed by Southern blotting, which produced
expected results for all UAS lines except those containing 128
repeats, which displayed repeat instability (Supplementary Fig.
1B) and were thus excluded from further analysis. DPR-only con-
structs using alternative codon sequences coding for poly-GA,
poly-GR, poly-PA and poly-PR were designed for eight amino
acids and 64 amino acids. Plasmid DNA was synthesized by
GeneArt (Life Technologies) and sent to BestGene for generation
of transgenic ﬂies. Constructs were integrated at site ZH-86FB for
UAS-DsRed2-(G4C2) constructs and attP40 for alternative codon
DPR only constructs. Genomic insertion was carried out by the
Cambridge transgenic ﬂy facility (Cambridge University, UK) and
BestGene, USA. Construction of UAS ﬂies carrying full-length
human TDP-43 (UAS-hTDP-43) and of ﬂies carrying genomic
construct NLS-TBPH was carried out as previously described
(Diaper et al., 2013). The NLS mutant (gNLS) was generated
by mutation containing PCR.
Reverse transcription PCR
RNA was extracted from homogenized ﬂy heads. The follow-
ing primers were used to assess TBPH mRNA levels: forward
primer: 50-ATCTTGGATGGCTCAGAACG-30, reverse primer:
50-GTCGGTCTTTATTCCGTTGG-30. RPL32 was used as a
loading control with the following primers: forward primer:
50-CGCCGCTTCAAGGGACAGTATC-30, reverse primer:
50-CGACAATCTCCTTGCGCTTCTT-30.
Southern and northern blotting
For Southern blotting, genomic DNA from 30 male ﬂies per
genotype was used. For northern blotting, RNA extraction
from 70 L3 larvae was carried out. Primers speciﬁcally
targeting a coding region of DsRed2 were used
(forward: 50-GTGATGCAGAAGAAGACCAT-30 and reverse:
50-CTTGGCCATGTAGATAGACT-30).
Generation of polyclonal and
monoclonal poly-GP antibodies
To generate rabbit polyclonal anti-polyGP, a custom-made
peptide sequence—GPGPGPGPGPGPGPGPGPGPGPGPGPGP
GP (GPx15)—was fused to the C-terminus of maltose-binding
protein. Two rabbits were immunized with the fusion protein
and the resulting serum was puriﬁed with GST-fusion proteins
containing (GP)15 at the C-terminus. Peptide generation and
immunization was carried out by Eurogentec. Mouse monoclo-
nal anti-polyGP (clone 2C20) was generated by immunization
of mice with the custom-made peptide sequence, GPGP
GPGPGPGPGPGPGPGP (GPx10), done by Abmart.
Western blotting
For Drosophila samples, heads from mated female ﬂies were
removed by snap freezing in liquid nitrogen and were then
homogenized in RIPA buffer. Total protein concentration was
measured using the BCA kit (Thermo Scientiﬁc). For detection of
insoluble protein, samples were lysed in RIPA buffer and then
spun at 16000g for 10 min, after which the supernatants were
separated from the pellets and prepared for western blot. The
pellets were washed three times with RIPA buffer then resus-
pended in urea buffer. For details see the Supplementary mate-
rial. Antibodies used were: rabbit anti-DsRed2 (1:1000,
Clontech); mouse monoclonal anti-GP (1:1000, this work);
mouse monoclonal anti-GA (clone 5E9) (1:1000, Merck
Millipore, MABN889); rabbit polyclonal anti-TBPH (1:2000)
(Diaper et al., 2013); mouse anti-TARDBP 2E2-D3 (1:100,
Abnova); rabbit anti-beta actin polyclonal (1:1000, Abcam);
mouse anti-beta tubulin monoclonal (1:600, DSHB); goat anti-
KPNA4 (1:750, Novus); rabbit anti-GAPDH (1:5000; Cell
Signaling Technology). The following secondary antibodies and
dilutions were used: polyclonal goat anti-rabbit IgG (H&L) con-
jugated IRDye800 (Rockland immunochemicals) used at 1:10
000 and polyclonal goat anti-mouse IgG (H&L) conjugated
Alexa Fluor 680 (Thermo Fisher) used at 1:10000.
Dot blotting for dipeptide-repeat
protein detection
Dot blots were used to detect DPRs using the protocol
described previously (Mizielinska et al., 2014). Primary anti-
bodies were used as described (Gendron et al., 2013; Mann
et al., 2013); for details see the Supplementary material.
Fluorescence in situ hybridization
Fluorescence in situ hybridization (FISH) was carried out as
described previously (Tran et al., 2015) using an Alexa
Fluor 488-labelled (G2C4)4 RNA probe. Salivary glands
were dissected and ﬁxed in 4% PFA and probed as described
for immunohistochemistry for mouse anti-phospho-RNA poly-
merase II 4H8 (1:500, Abcam) and secondary antibody used
was Alexa Fluor 568 (Life Technologies). For details see the
Supplementary material.
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Immunohistochemistry
Larval CNS, larval salivary glands, larval and pupal eye discs,
and adult brains were immunolabelled using rabbit anti-GFP
1:1000 (Invitrogen), rabbit polyclonal anti-GP (1:1000, this
work), mouse monoclonal anti-GA (1:500, Merck Millipore),
anti-GR rat monoclonal (1:300, Merck Millipore), mouse anti-
HA clone 6E2 (1:500, Cell Signal), rabbit anti-TBPH (1:2000)
(Diaper et al., 2013), rabbit anti-RanGAP (1:300, kind gift
from C. Staber); rabbit anti-Importin-a3 (1:300, kind gift
from S. Cotterill); rabbit anti-Pendulin (1:300) and mouse
anti-dRCC1 (1:10) (both kind gifts from M. Frasch); mouse
monoclonal anti-MAB414 (1:500, Abcam), rabbit anti-NUP50
(1:10000, kind gift from J. Großhans), and rabbit anti-REF2P
(1:1000, kind gift from D. Contamine). Secondary antibodies
conjugated to Alexa Fluor 488, 568 and 647 (Life
Technologies) were used at a ﬁnal concentration of 1:150.
See the online Supplementary material for details.
Image acquisition and analysis
Images were obtained either with Motic BA400 or Leica TCS
SP5 confocal microscopes. For quantiﬁcation of the TBPH nu-
clear/cytoplasmic ratio, brains were dissected and washed in
primary antibody solution. Single plane images were taken
from the medulla of the adult brain always analysing the
same region. Nuclear was deﬁned by DAPI labelling, TBPH
immunolabelling was distinguished by nuclear/DAPI and non-
nuclear/non-DAPI. Eight brains of each genotype were used for
measurements, which were carried out using ImageJ.
Eye sectioning
Parafﬁn eye sections were done as previously described
(Zaharieva et al., 2015).
Larval survival
Embryos were collected at 5-h intervals by replacement of fruit
agar plate. L1 larvae were transferred to vials of standard
cornmeal media at a density of 50 larvae per vial. Number
of ﬂies that underwent complete eclosion were counted.
Percentage of ﬂies surviving was calculated based on the ori-
ginal L1 population of 50.
Larval peristalsis
L3 larvae were placed in the centre of fruit agar plates that
had been left at room temperature for 30min. L3 larvae were
left to acclimatize for 1min, after which the number of peri-
staltic waves that occurred in the following minute were
counted.
Startle-induced negative geotaxis
Startle-induced negative geotaxis (SING) was carried out fol-
lowing White et al. (2010).
Video-assisted motion tracking
Activity tracking was carried out as previously described
(White et al., 2010). In addition, activity was deﬁned as
movement per frame above a velocity of 2mm/s. Raster
plots and activity per minute graphs were generated in
MATLAB using custom script. Percentage of time active over
the recording period was calculated for each ﬂy. These data
were exported to GraphPad Prism 6 for statistical analysis.
Human post-mortem tissue analysis
Brain tissue samples were provided from the London
Neurodegenerative Diseases Brain Bank (King’s College
London, UK). Consent for autopsy, neuropathological assess-
ment and research were obtained and all studies were carried
out under the ethical approval of the tissue bank (08/MRE09/
38+5). Block taking for histological and immunohistochemical
studies and neuropathological assessment for neurodegenera-
tive diseases was performed in accordance with standard cri-
teria. Fifteen cases were used for the western blot experiments,
ﬁve FTLD-TDP without the C9orf72 expansion, ﬁve FTLD-
TDP with conﬁrmed C9orf72 expansion and ﬁve control
cases. Controls were deﬁned as subjects with no clinical history
and no neuropathological evidence of a neurodegenerative
condition.
For western blot analysis, fresh-frozen post-mortem tissue was
homogenized in 10 v/w of high salt buffer [100 mM 2-(N-mor-
pholino) ethane sulphonic acid (MES) (pH 7.4), 0.5mM MgCl2,
1mM EGTA, 1M NaCl, 50mM imidazole, protease inhibitor
cocktail (Roche)]. The homogenate was mixed with 2% SDS-
PAGE loading buffer and boiled for 10min. Samples were cen-
trifuged for 20min at 13 000 rpm and 4C. Equal volumes of
samples were loaded on 26-well NuPAGE Novex 10% Bis–
Tris pre-cast gels (Invitrogen). Western blots were performed as
described (Nishimura et al., 2010). For detection of insoluble
protein, the same protocol was used as for ﬂy tissue.
For immunohistochemistry and immunoﬂuorescence of post-
mortem human brain samples, the protocols were carried out as
previously described (Maekawa et al., 2004). Brieﬂy, 7mm thick
sections from the frontal cortex were cut from formalin-ﬁxed
parafﬁn-embedded tissue blocks and sections were microwaved
in citrate buffer to enhance antigen retrieval. For immunoﬂuores-
cence, primary antibodies were used at the following concentra-
tions; rabbit polyclonal anti-GP (1:1000, this study); mouse
monoclonal anti-GA (1:500, Merck Millipore); anti-GR rat mono-
clonal (1:50, Merck Millipore); rabbit phospho-TDP-43 (1:500,
pS409/410-1; 2B Scientiﬁc); mouse phospho-TDP-43 (1:500,
pS409/410-1, Cosmo Bio Co., LTD); mouse anti-TARDBP 2E2-
D3 (1:100, Abnova); rabbit anti-KPNA4 (1:250, Novus).
Secondary antibodies conjugated to Alexa Fluor 488, 568 and
647 (Life Technologies) were used at a ﬁnal concentration of
1:250. Autoﬂuorescence was quenched using Sudan black treat-
ment and sections were mounted using Vectashield with DAPI.
For immunohistochemistry, primary antibody rabbit anti-KPNA4
(1:500, Novus) was applied overnight at 4C. Following washes,
sections were incubated with biotinylated secondary antibody
(Dako), followed by avidin:biotinylated enzyme complex
(Vectastain Elite ABC kit, Vector Laboratories). Finally, sections
were incubated for 5–10min with 0.5mg/ml 3,30-diaminobenzi-
dine chromogen (Sigma-Aldrich) in Tris-buffered saline (pH 7.6)
containing 0.05% H2O2. Sections were counterstained with
Harris’ haematoxylin. Immunostaining (morphology, location
and intensity) was examined and assessed by a consultant neuro-
pathologist (T.H.) blind to diagnosis.
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Statistical analysis
GraphPad Prism 6 was used to perform the statistical analyses
indicated within the ‘Results’ section. Comparison of means was
performed using either an unpaired t-test, one- or two-way
ANOVA, or Bonferroni’s multiple comparisons test. Post hoc
analysis was conducted using Fisher’s least signiﬁcant difference
(LSD) test or the Bonferroni-Holm method (Holm, 1979). For
categorical data, Fisher’s exact test was preferred to Pearson’s
chi-squared test due to small sample sizes in this dataset.
Data availability
The authors conﬁrm that the data supporting the ﬁndings of
this study are available within the article and its
Supplementary material.
Results
Novel Drosophila models of
C9ALS/FTD produce different
combinations and levels of
G4C2-derived RNA and DPRs
To investigate G4C2/DPR-related TDP-43 pathology, novel
Drosophila models of C9ALS/FTD, expressing different
lengths of uninterrupted G4C2 repeats in the 30 UTR of the
disease-unrelated DsRed2 gene, were ﬁrst created (Fig. 1A).
Previous studies have shown that introduction of non-coding
CAG repeats in the 30 UTR of the DsRed2 gene, but not
DsRed2 itself, is sufﬁcient to induce age-related neurodegen-
eration in a sequence-speciﬁc manner (Li et al., 2008). This
strategy was applied to directly regulate the number of G4C2
repeats used (Supplementary Fig. 1A–C). Variable linker se-
quences in between the DsRed2 stop codon and start of the
G4C2 repeats were introduced by chance because of the clon-
ing strategy utilized (Fig. 1A and Supplementary Fig. 1D).
Western and dot blot analyses identiﬁed sense, but not anti-
sense DPRs, in ﬂies expressing 532 repeats (Fig. 1B–D), the
levels and combinations of which correlated with the corres-
ponding linker sequence 50 of the G4C2 repeats. High levels
of poly-GP and poly-GA were observed in 32 and 64 repeat
lines (Fig. 1B and C) that contain the same 50 linker sequence;
however much lower levels were seen in 38 and 56 repeat
lines, both of which had their own unique 50 linker sequence
(Fig. 1A–C and Supplementary Fig. 1D). Hence DPR expres-
sion proﬁles were dependent on the 50 linker sequence for
G4C2 repeats of different length (Table 1) and independent
of a near-cognate CUG codons 50 of the repeats
(Supplementary Fig. 1D), which has been recently related to
G4C2 RAN translation (Green et al., 2017; Tabet et al.,
2018). Of note, poly-GR was only detected in ﬂies expressing
38 repeats (Fig. 1D and E and Supplementary Fig. 3I). The
expression characteristics of these Drosophila models allowed
us to assess the toxicity of different levels and combinations
of G4C2 RNA and DPRs.
Time of disease onset and severity
depend on levels and combinations of
G4C2-derived RNA/DPRs
To address the toxic potential of these different constructs,
survival of larvae over-expressing G4C2 repeats under con-
trol of the pan-neuronal ElavC155 driver was measured.
Surprisingly, despite neuronal overexpression of potentially
pathogenic G4C2 repeat lengths in all experimental geno-
types, toxicity was observed in a construct-dependent
manner. No signiﬁcant impairment in survival was reported
in ﬂies expressing 8, 32, 56 or 64 repeats relative to ﬂies
expressing DsRed2 without G4C2 repeats (Supplementary
Fig. 2). These ﬁndings suggest that G4C2 repeat RNA up
to 64 repeats in length and the concomitant presence of
poly-GA and poly-GP at high expression levels, are well
tolerated during development. In contrast, larvae expressing
38 repeats demonstrated a signiﬁcant impairment in sur-
vival relative to all other G4C2 repeat expressing larvae
and negative controls. This toxicity was not due to the
genomic insertion of the UAS construct as 38 repeat ﬂies
also exhibited signiﬁcant survival impairment relative to the
UAS control ( + /DsRed2-38). To establish whether this tox-
icity was conserved in a different genetic background, UAS
lines were backcrossed six times to white1118. Following
this procedure, expression of 38 repeats remained toxic to
developing larvae as evidenced by signiﬁcantly impaired
survival relative to all other genotypes tested
(Supplementary Fig. 2).
To establish the impact of neuronal G4C2 repeat expres-
sion over time, adult locomotor performance was assessed
in young (Day 5), mid-aged (Day 20) and older (Day 40)
ﬂies. Following mechanical disruption, ﬂies were ﬁrst tested
for their SING response, which, after being overthrown,
quantiﬁes their ability to right themselves and climb up
the test tube (White et al., 2010). Analysis revealed that
by Day 5, ﬂies expressing 38 repeats displayed severely
impaired climbing performance relative to all other geno-
types (Fig. 1F–J). By Day 20, the poor performance in the
38 repeat ﬂies had progressed to a complete inability to
climb. By Day 40, ﬂies expressing 38 repeats had already
died, whereas a signiﬁcantly impaired motor behaviour was
detectable for 32 and 64 repeat ﬂies. Comparable ﬁndings
were observed with video-assisted motion tracking in an
open-ﬁeld assay where freely moving ﬂies were recorded
for 60min to determine their activity bouts and movement
trajectories (Supplementary Fig. 3A–E).
To rule out that these differences in toxicity were due to
potential differences in Gal4/UAS expression levels (despite
identical genomic insertion sites), ﬂies were generated
harbouring two copies of the 64 repeat construct that pro-
duce signiﬁcantly higher levels of DsRed2 protein
(Supplementary Fig. 3F). SING analysis at Day 5 of these
2  64 ﬂies was compared to single copy 64 ﬂies and the
38 repeat line. This revealed the climbing performance
between 2  64 repeat ﬂies and 1  repeat 64 ﬂies was
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Figure 1 Drosophila C9ALS/FTD models expressing G4C2 RNA and different levels and combinations of RAN-translated
DPRs. (A) Schematic of constructs with different lengths of uninterrupted G4C2 repeats cloned into 30 UTR of disease-unrelated marker gene
DsRed2; variable linker sequences between DsRed2 stop codon and start of G4C2 repeats are indicated. (B and C) Quantitative western blot for
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not signiﬁcantly different; however, both were signiﬁcantly
different to the severely impaired 38 repeat ﬂies
(Supplementary Fig. 3G). Given the construct-dependent,
different G4C2 RNA and DPR expression levels, these
data establish that high levels of poly-GA and poly-GP ac-
cumulation correlate with late onset, whereas poly-GR ac-
cumulation correlates with rapid onset and progression of
disease (Table 1). These ﬁndings were further corroborated
by enhanced age-related neurodegeneration, which by Day
35 was only observed in the 38 but not in 64 repeat or 8
repeat control ﬂies (Supplementary Fig. 3H). Together these
data establish that cellular toxicity in our C9 model is de-
pendent on levels and identity of G4C2 RNA and/or DPRs
produced rather than length of the repeat.
DPR but not G4C2 RNA cause
TDP-43 accumulation
Previous studies correlated G4C2 repeats with TDP-43 mis-
localization but did not distinguish between RNA and/or
DPR mediated pathology and onset of disease (Freibaum
et al., 2015; Zhang et al., 2015). We therefore investigated
the expression and localization of the Drosophila TDP-43
homologue (Diaper et al., 2013) TBPH in our models. No
signiﬁcant differences in mRNA and protein levels of TBPH
were seen by Day 5, regardless of the G4C2 repeats ex-
pressed (Fig. 2A). However, by Day 5, TBPH was misloca-
lized to the cytosol in 38 repeat ﬂies, but not in 64 repeat
expressing ﬂies that showed TBPH mislocalization by Day
50 (Fig. 2C), thus correlating with later onset of disease.
To distinguish between RNA and DPR mediated TBPH mis-
localization, we next created transgenic ﬂies producing different
lengths of non-G4C2-derived DPR (Fig. 2B). Consistent with
previous reports (Mizielinska et al., 2014), expression of argin-
ine-rich poly-GR64/PR64 but not of eight amino acid length
was highly toxic (Supplementary Fig. 4). Targeted expression in
development and adult-speciﬁc tissue identiﬁed 64 amino acid
DPRs initially accumulated in the cytoplasm and in the case of
poly-GR formed additional aggregates within 48h in larval eye
disc (Supplementary Fig. 5A) and by 18 days in adult brain
neurons (Supplementary Fig. 5B). Moreover, accumulating
poly-GA64 but not poly-GR64 formed inclusions that co-loca-
lized with Ref2P, the Drosophila homologue of p62
(Supplementary Fig. 6A). Consistent with DPR-initiated TDP-
43 pathology in humans, targeted expression of non-G4C2
derived poly-GR64 and poly-GA64, caused cytoplasmic accu-
mulation of TBPH. In all cases examined (n = 30) poly-GR64
expression caused an extensive diffuse cytoplasmic accumula-
tion of TBPH (Fig. 2B, asterisks), whereas poly-GA64 expres-
sion resulted in cytoplasmic TBPH aggregates that frequently
co-localized with poly-GA inclusions (Fig. 2B, arrowheads).
To rule out G4C2 RNA-mediated TBPH mislocalization,
a previously characterized RNA only ﬂy line 288RO was
used, which produces high amounts of G4C2 RNA, is not
subject to RAN translation and causes RNA foci formation
(Mizielinska et al., 2014). Of note, 288RO expression did
not cause any alterations in TBPH localization, which ap-
peared indistinguishable from controls (Fig. 2D). Moreover,
Ref2P-positive inclusions were not seen in these 288RO-
expressing ﬂies (Supplementary Fig. 6A). Furthermore,
Table 1 Expression levels and disease onset of G4C2 repeats and derived DPRs in Drosophila
G4C2 repeats G4C2 levela DPR type DPR levelb Motor
phenotype
8 n/a None n/a None
32 + GA/GP + + + / + + + at Day 40
38 + + GA/GP/GR + + / + / + at Day 5
56 + GA/GP + / + + not at Day 40
64 + GA/GP + + + / + + + at Day 40
64  2 + + GA/GP + + + + / + + + + not at Day 5
aBased on northern blots and quantitative western blots for DsRed2 protein of DsRed2-G4C2 constructs.
bBased on quantitative western blots and in situ expression of respective DPR.
Figure 1 Continued
poly-GP (B) and poly-GA (C) of head extracts of 5-day-old flies expressing G4C2 repeats pan-neuronally (Elav-Gal4); P5 0.0001; *significant
difference from all other genotypes; mean with SEM shown for each genotype (n = 3). (D) Dot blot analysis of adult fly head extracts of G4C2
constructs using two published poly-GR antibodies; positive control ( + ) of lysate from HEK293 cells expressing poly-GR from a non-G4C2
template. No anti-sense DPRs were detected using anti-PR and anti-PA antibodies, with beta-tubulin as loading control. (E) Confocal images of
nervous system of Elav-Gal4 mediated pan-neuronal expression of controls and G4C2 repeats. Immunohistochemistry of 5-day-old adult brains
shows poly-GR detectable in flies expressing 38 G4C2 repeats but not in controls. In flies expressing 38 G4C2 repeats, poly-GR displays diffuse
perinuclear localization with regions of intense staining. Scale bars = 10 mm. (F–H) Geotaxis climbing performance at Day 5 (F), Day 20 (G) and
Day 40 (H) of flies expressing different G4C2 repeats that lead to different levels of poly-GA and poly-GP produced. Note that flies expressing 32
and 64 show motor impairment by Day 40, but not 56 G4C2 repeats nor control constructs; **P5 0.01; mean with SEM shown for each
genotype (n = 7–14). (I and J) Geotaxis climbing performance of flies expressing 38 repeats at Day 5 (P5 0.001) and Day 20 (P5 0.001)
compared to controls; mean with SEM shown for each genotype (n = 3–5).
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with exception of a single focus identifying polymerase II
activity, RNA foci were not detectable in any of our G4C2
RNA expressing ﬂies (Supplementary Fig. 6B). Together
these data demonstrate that DPRs but not G4C2 RNA
foci cause cytoplasmic mislocalization of TDP-43, which
correlates with onset of disease.
Accumulating cytoplasmic TDP-43
enhances levels of RAN translated
DPRs and C9-related motor
impairment
Cytosolic TDP-43 functions in mRNA stability, translation
and transport (Ederle and Dormann, 2017) however imbal-
anced cytoplasmic accumulation can induce its nuclear de-
pletion and aggregate formation (Winton et al., 2008), both
of which are causally related to onset and progression of
disease (Lee et al., 2011; Robberecht and Philips, 2013).
This dual impact of accumulation-related loss and gain of
TDP-43 function raises the possibility that DPR-triggered
TDP-43 dysfunction propagates C9-related toxicity.
To investigate this hypothesis, we generated a TBPH con-
struct with mutated nuclear localization signal (NLS-
TBPH) under control of the endogenous TBPH promoter
(Fig. 3A). Expression of NLS-TBPH resulted in cytoplas-
mic accumulation and subsequent nuclear depletion of
TBPH (Supplementary Fig. 7A–H), eventually causing neu-
rodegeneration in a dose-dependent manner (Supplementary
Fig. 7I). Analysis of RIPA and urea protein fractions of adult
head extracts showed that TBPH toxicity was unrelated to
urea-soluble aggregates (Supplementary Fig. 7J). This was
independently conﬁrmed by expressing either wild-type or
aggregate forming mutant human TDP-43 missing RNA
Recognition Motif 1 (RRM1-TDP-43) (Ihara et al.,
2013), which revealed high toxicity of TDP-43 did not
Figure 2 DPR but not RNA accumulation causes cytoplasmic mislocalization of Drosophila TDP-43, TBPH. (A) RT-PCR and
quantitative western blot analyses of head extracts from 5-day-old flies expressing G4C2 repeats pan-neuronally reveals no significant effect of
genotype on TBPH expression level; western blot mean with SEM shown (n = 3). Confocal images of Day 5 adult brains with anti-TBPH
immunostaining in cytoplasm and nucleus (n = 4). Quantification of nuclear/cytoplasmic ratio in flies expressing 38 G4C2 repeats compared to
control and flies expressing 64 G4C2 repeats; *P5 0.05, mean with SEM shown (n = 4). (B) Top: schematic depicting non-G4C2 alternative codon
constructs designed to produce different lengths of pure DPR (8 aa and 64 aa) flanked by 50 Myc tag and 30 HA tag. Bottom: salivary glands of
indicated genotypes immunolabelled with anti-TBPH and anti-HA to detect DPR distribution. Compared to controls, poly-GA64 expression
causes cytoplasmic TBPH aggregates that co-localize with poly-GA inclusions (arrowheads); poly-GR64 expression leads to diffuse cytoplasmic
mislocalization of TBPH (asterisks) in all cases examined (n = 30). Note, poly-GR64 expression also causes enlarged nuclei compared to controls.
(C) Cytoplasmic mislocalization of TBPH is seen by Day 50 in flies expressing 64 G4C2 repeats compared to control flies expressing eight G4C2
repeats; Right: quantification of nuclear/cytoplasmic ratio; *P5 0.005, mean with SEM shown (n = 4). (D) Expression of G4C2 RNA only (288RO)
does not alter TBPH localization compared to controls. Scale bars = 10 mm (A and C); 20 mm (B and D).
DPRs trigger TDP-43 proteinopathy BRAIN 2018: 141; 2908–2924 | 2915
D
ow
nloaded from
 https://academ
ic.oup.com
/brain/article-abstract/141/10/2908/5104292 by King's C
ollege London user on 17 O
ctober 2018
Figure 3 Accumulating cytoplasmic TBPH enhances G4C2-related motor impairment and levels of DPRs produced, and
causes karyopherin-a pathology. (A) Schematic of genomic TBPH region indicating exon (black boxes) intron structure, protein coding start
(ATG) and stop codon (TAA); pink asterisk indicates bipartite nuclear localization signal (NLS) for wild-type (WT) TBPH and mutant (NLS)
constructs subcloned into pUC 3GLA vector and inserted by site-specific integration at ZH86Fb on the third chromosome. (B) Day 5 motor
performances of control flies and flies co-expressing NLS-TBPH with 64 or 38 G4C2 repeats; ***P5 0.001, mean with SEM shown (n = 4).
(C and D) Quantitative western blots for poly-GP (C) and poly-GA (D) using Day 5 head extracts of controls and flies co-expressingNLS-TBPH
with 64 and 38 G4C2 repeats; **P5 0.01, ***P5 0.001; mean and SEM shown (n = 3). (E) Immunostaining of importin-a3 (KPNA4) in salivary
gland cells reveals loss of nuclear staining in NLS-TBPH (gNLS) (n = 12). Also, immunostaining of pendulin (KPNA2) in salivary gland cells
reveals loss of nuclear staining as well as cytoplasmic accumulation in NLS-TBPH (gNLS) (n = 12). Comparable cytosolic mislocalization and
reduced nuclear staining of importin-a3/KPNA4 can be seen in flies expressing either full-length human TDP-43 or its disease-related mutant
Q331K. No nuclear depletion of importin-a3 was seen in controls or homozygous TBPH null mutant. MAB414 immunolabelling recognizing the
conserved FG motif in Nup62, Nup153, Nup214 and Nup358 appears unaltered between controls, NLS-TBPH and hTDP-43 or Q331K. Scale
bars = 10 mm. ns = not significant.
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correlate with the formation of TDP-43-positive urea-soluble
inclusions (Supplementary Fig. 7K–M). These data suggest
that accumulating cytosolic but not aggregated TDP-43
causes onset of disease and C9-related toxicity.
To test this hypothesis further, we co-expressed NLS-
TBPH with 38 and 64 G4C2 repeats and measured the
motor behaviour of these ﬂies compared to controls.
SING analysis revealed that by Day 5, no signiﬁcant im-
pairment in the motor behaviour of 64,NLS-TBPH ﬂies
was detectable, but exacerbated motor impairment in
38,NLS-TBPH ﬂies at this time point when compared
to 38 repeat only ﬂies and controls (Fig. 3B). Notably,
co-expression of NLS-TBPH led to increased levels of
DPRs in both 64 and 38 G4C2 repeat ﬂies, as exempliﬁed
by quantitative western blotting for poly-GP (Fig. 3C) and
poly-GA (Fig. 3D). Together these data demonstrate that
accumulation of cytosolic TDP-43 enhances G4C2-related
toxicity and increases levels of DPRs, thus identifying a
vicious cycle between TDP-43 and DPR accumulation
and the propagation of C9-related toxicity.
Dipeptide-repeat protein
accumulation causes KPNA but
not RanGAP or nuclear pore
complex pathology
Several recent studies reported NCT and NPC deﬁcits in
G4C2 RNA and DPR expression models (Freibaum et al.,
2015; Jovicic et al., 2015; Zhang et al., 2015; Boeynaems
et al., 2016), and most recently also in models of TDP-43
aggregation (Chou et al., 2018), indicating that C9-related
NCT and/or NPC defects mediate disease but so far it re-
mains unclear whether TDP-43 pathology is a cause or
consequence of it.
To address this question, we ﬁrst investigated whether
accumulation and aggregation of either poly-GA or poly-
GR affects the expression and localization of NCT and
NPC core components in our C9ALS/FTD models. When
expressed in salivary gland cells, we detected already in
larval L3 stage perinuclear/cytoplasmic accumulation of
KPNA homologues importin-a3 (KPNA4) and pendulin
(KPNA2) in ﬂies expressing poly-GA64 or poly-GR64,
but not in controls, nor in G4C2 RNA only. Of note, ex-
pression of poly-GR64, but not of poly-GA64, also caused
nuclear depletion of both importin-a3 and pendulin,
whereas expression of poly-GA64 resulted in cytoplasmic
inclusions of importin-a3 and pendulin that overlap with
poly-GA (Fig. 4A and B).
Conversely, in spite of strong poly-GR toxicity and ag-
gregate formation, no obvious alterations for the NCT
component RanGAP were seen (Fig. 4C). Similarly, poly-
GR64 expression did not affect localization of dRCC1, the
Drosophila homologue of Regulator of chromosome con-
densation 1, a guanine nucleotide exchange factor for Ran
GTPase, whereas we detected cytoplasmic dRCC1 inclu-
sions that overlap with poly-GA (Supplementary Fig. 6C).
Moreover, when analysing NPC architecture, MAB414
immunolabelling, which recognizes the conserved FG
motif (Capelson et al., 2002) in nuclear pore proteins
Nup62, Nup153, Nup214 and Nup358, we did not ob-
serve any differences between controls, 288RO (G4C2
RNA only), poly-GR64 or poly-GA64 expression in all
cases examined (n4 10), despite the presence of DPR in-
clusions (Fig. 4D). Also, Nup50 immunolabelling, which
detects a soluble cofactor of importin a / b-mediated cargo
transport (Lindsay et al., 2002) across the NPC, did not
reveal differences between controls and 288RO, poly-GR64
or poly-GA64 expression (Supplementary Fig. 6D).
Collectively, these data suggest that in our Drosophila
models of C9ALS/FTD, DPR-triggered disease onset correl-
ates with mislocalization and nuclear depletion of KPNA2
and 4, but not with NPC or other NCT deﬁcits.
Accumulating cytosolic TBPH causes
KPNA pathology
KPNA2 and KPNA4 are members of the karyopherin-a
family and part of the classical nuclear import pathway
(Prpar Mihevc et al., 2017). Direct protein–protein inter-
actions between TDP-43 and KPNA2/4 have already been
demonstrated (Freibaum et al., 2010; Nishimura et al.,
2010; Chou et al., 2018) and dataset of RNA targets of
TDP-43 shows that it can bind to KPNA4 pre-mRNA and
to a lesser extent, KPNA2 (Tollervey et al., 2011).
Moreover, KPNAs bind poly-GR/PR (Lee et al., 2016)
and are sequestered into cytoplasmic inclusions by b-pro-
tein aggregates (Woerner et al., 2016), including fragments
of TDP-43. Given that DPR accumulation triggers cytoplas-
mic mislocalization of TDP-43 (Fig. 2B), we asked whether
accumulating cytosolic TDP-43 is itself sufﬁcient to cause
KPNA pathology.
To address this question, we ﬁrst focused on NLS-
TBPH that accumulates in the cytoplasm, leads to nuclear
TBPH depletion and causes age-related neurodegeneration
(Supplementary Fig. 7), thus recapitulating disease-related
TDP-43 pathology that also characterizes the majority of
C9ALS/FTD cases. Interestingly, NLS-mediated cytoplas-
mic accumulation of TBPH caused cytosolic mislocalization
and nuclear depletion of pendulin/KPNA2, and a nuclear
loss of importin-a3/KPNA4. We then investigated whether
comparable phenotypes can be observed with full-length
wild-type human TDP-43 and the disease-related mutant
Q331K. Targeted expression of either UAS-hTDP-43 or
UAS-Q331K-hTDP-43 (Elden et al., 2010) caused cytosolic
mislocalization and reduced nuclear staining of importin-
a3/KPNA4 that was not seen in controls or in TBPH null
mutants (Fig. 3E). In contrast, MAB414 immunolabelling
did not reveal any apparent differences between controls,
NLS-TBPH and full-length human TDP-43 or its disease-
related mutant form Q331K (Fig. 3E). Together these data
demonstrate that even in the absence of G4C2 RNA/DPRs,
accumulating TDP-43 is sufﬁcient to induce KPNA
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Figure 4 DPR but not G4C2 RNA accumulation causes karyopherin-a pathology. Confocal images of larval L3 stage salivary gland
cells expressing either non-G4C2, alternative codon-derived DPRs (DPR only) or G4C2 RNA only (288RO) immunolabelled with anti-HA to
detect DPR distribution. (A and B) Additional immunostaining for the karoypherin-as, importin-a3 (KPNA4) and pendulin (KPNA2) reveals
cytoplasmic inclusions that co-localize with poly-GA64 and nuclear depletion in cells expressing poly-GR64, but not in controls or cells expressing
288 G4C2 repeat RNA only. Scale bars = 10mm. (C and D) Additional immunolabelling with anti-RanGAP (C) and anti-MAB414 (D). No changes
are seen in localization of these proteins in DPR only and RNA only constructs compared to the controls. Both RanGAP and MAB414 distribution
is perinuclear. Scale bars = 10mm.
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pathology and suggest that TDP-43 mediated nuclear
import deﬁcits initially occur devoid of NPC morphology
defects.
KPNA4 pathology is detectable in
both sporadic FTD and C9ALS/FTD
human frontal cortex
The results of our experiments signify that DPR-triggered
dysfunction of TDP-43 and in turn of KPNAs propagate
onset and progression of C9-related neurodegeneration.
Consequently, several predictions can be deduced and
their validity tested. First and foremost, the reported ﬁnd-
ings translate into human patients and predict KPNA path-
ology can be found in C9ALS/FTD but also in sporadic
cases devoid of G4C2 repeat expansion. Second, the vicious
cycle of DPR-initiated TDP-43 and KPNA pathology pre-
dicts that both DPR and TDP-43 inclusions correlate with
KPNA pathology, but all three may not be found in the
very same cell. To test these predictions, we focused on
KPNA4 and examined its expression level and localization
in post-mortem human frontal cortex of C9ALS/FTD and
sporadic FTD cases with TDP-43 pathology (sFTD-TDP),
and compared it to age-matched controls (each n = 8).
Analysis of RIPA and urea protein fractions revealed in-
soluble aggregates remaining in the wells and lowered ex-
pression levels of soluble KPNA4 in both sFTD-TDP and
C9ALS/FTD, but not in controls (Fig. 5A and B). KPNA4
immunoreactivity in controls revealed a uniform distribu-
tion in neurons with both nuclear and cytoplasmic labelling
(Fig. 5C and Supplementary Fig. 8A–D). In contrast, immu-
nohistochemical analysis in both sporadic FTD-TDP
and C9ALS/FTD cases identiﬁed nuclear depletion of
KPNA4 that was further pronounced in C9ORF72 cases
(Fig. 5C). However, we also observed nuclear inclusions in
both sporadic FTD-TDP and C9ALS/FTD that often were
conﬁned to KPNA4-immunoreactive nucleolus within a
KPNA4-negative nucleus (Supplementary Fig. 8F and J).
Furthermore, neuronal processes consistent with axons and
dystrophic neurites were detectable in C9ORF72 cases
(Supplementary Fig. 8L).
The observed KPNA4 pathology overlapped with immu-
noreactivity against phosphorylated TDP-43 (Fig. 6A,
arrowheads). Notably, however, KPNA4 pathology, espe-
cially its nuclear depletion, was frequently observed in cells
without phospho-TDP-43 labelled inclusions in both spor-
adic FTD-TDP and C9ORF72 cases (Supplementary Fig. 9,
arrows). Moreover, in C9ALS/FTD tissue sections, poly-
GA, poly-GP and poly-GR inclusions were detectable that
overlapped with KPNA4 pathology (Fig. 6B, arrows), but
as was the case for phospho-TDP-43 labelled inclusions,
nuclear depletion of KPNA4 was frequently observed
in cells devoid of sense DPR inclusions (Supplementary
Fig. 10, arrows). These ﬁndings identify KPNA4 and
TDP-43 pathology as a common denominator of sporadic
FTD and C9ALS/FTD, and together with our functional
data in Drosophila strongly suggest that TDP-43 misloca-
lization is not just a consequence of defective nuclear
import but rather a direct contributor to it.
Discussion
Our ﬁndings reported here provide experimental and
pathological evidence for a sequence of events in which
DPR-triggered TDP-43 accumulation causes KPNA path-
ology that precedes C9orf72-related neurodegeneration
(Fig. 6C). Timing and extent of TDP-43 mislocalization
was dependent on levels and identity of DPRs produced.
Thus, early cytosolic accumulation and disease onset was
observed in the poly-GR producing 38 repeats, and late
cytosolic accumulation and disease onset occurred in
poly-GP/poly-GA producing lines. Importantly, our
C9ALS/FTD models demonstrate that, rather than the
length of the G4C2 repeat RNA, toxicity correlates with
levels and identity of DPR produced, which is the key stres-
sor causing cytosolic mislocalization of TDP-43 and onset
of disease.
A hallmark of TDP-43 proteinopathies is their close cor-
relation between observed clinical phenotypes, degree of
neurodegeneration, and regional distribution and severity
of TDP-43 pathology (Geser et al., 2009). This close cor-
relation is also observed in the majority of C9ALS/FTD
cases, which in addition to TDP-43 pathology are charac-
terized by RNA foci and ubiquitin positive/TDP-43 nega-
tive inclusions of G4C2-derived DPRs (Mackenzie et al.,
2015). However, neither RNA foci nor DPR inclusions,
especially the most abundant poly-GA and poly-GP de-
posits, correlate with clinical symptoms and neurodegenera-
tion (Mann, 2015). A notable exception has been recently
reported in C9ALS cases, which identiﬁed cytoplasmic
poly-GR inclusions associated with TDP-43 accumulation
and site of disease (Saberi et al., 2018). These neuropatho-
logical observations suggest a causal link between the
hexanucleotide repeat expansion, DPR accumulation and
TDP-43 pathology, indicating that TDP-43 dysfunction
might be the likely effector of neuronal loss in C9ALS/FTD.
Such a sequence of events is in agreement with the re-
cently discovered NCT and NPC defects in C9ALS/FTD
(Freibaum et al., 2015; Jovicic et al., 2015; Zhang et al.,
2015; Boeynaems et al., 2016). These studies revealed that
targeted genetic manipulation of NCT or NPC genes is able
to rescue, at least in part, cellular phenotypes and tissue-
speciﬁc neurodegeneration in cell and animal models
expressing 530 G4C2 repeats (Freibaum et al., 2015;
Zhang et al., 2015), poly-GR (Lee et al., 2016), or poly-
PR (Jovicic et al., 2015; Boeynaems et al., 2016). Yet, TDP-
43 pathology has not been reported for NCT or NPC gene
mutations or their protein dysfunction. Moreover, several
C9ALS/FTD mouse models reported that neurodegenera-
tion only occurred in the presence of TDP-43 pathology
(Chew et al., 2015; O’Rourke et al., 2015; Peters et al.,
2015; Liu et al., 2016), and clinico-pathological evidence
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(Proudfoot et al., 2014; Baborie et al., 2015; Vatsavayai
et al., 2016) revealed DPR pathology precedes that of
TDP-43. Furthermore, NPC deﬁcits have been observed
in association with TDP-43 pathology devoid of G4C2
repeat expansion (Chou et al., 2018). This is in agreement
with our observation that overexpression of full-length
human TDP-43 and its Q331K disease-related mutant,
are sufﬁcient to cause importin-a3 nuclear loss and cyto-
plasmic mislocalization. Wild-type TDP-43 expression has
been described as detrimental in ﬂies, even without
Figure 5 KPNA4 pathology in both sporadic FTD-TDP and C9ALS/FTD human frontal cortex. (A) Western blot analysis of
extracts from post-mortem frontal cortex of patients with sporadic FTD-TDP, C9ALS/FTD and control brain samples. Accumulated KPNA4 is
found in the insoluble fraction of sporadic FTD-TDP and C9ALS/FTD samples (black arrow), but not in controls. (B) Quantitative analysis of
western blotted soluble KPNA4 reveals its downregulation in sporadic FTD-TDP and C9ALS/FTD, but not in control (n = 8; *P5 0.03,
Bonferroni’s multiple comparison). (C) KPNA4 immunostaining in neurons of control cases reveals uniform distribution in both nucleus and
cytoplasm (arrows). In sporadic both FTD-TDP and C9ALS/FTD cases, immunolabelling reveals nuclear depletion and cytoplasmic accumulation
of KPNA4 (arrows). Scale bar = 50 mm.
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cytoplasmic accumulation (Hanson et al., 2010).
Furthermore, other studies in Drosophila (Choksi et al.,
2014) have revealed that phosphorylation of TDP-
43Q331K leads to formation of SDS-stable oligomers,
which may start sequestering surrounding proteins, such
as importin-a3. These data suggest that wild-type and
mutant TDP-43 overexpression can cause a KPNA pheno-
type in the absence of DPR pathology, resulting in nuclear
depletion and cytoplasmic mislocalization of the KPNAs.
However, a limitation when considering the human condi-
tion is that some of the conclusions of the study derive
from results obtained using constructs that are artiﬁcially
expressed in fruit ﬂies. Nevertheless, our data indicate that
G4C2 RNA and/or DPRs act as initiating stressors causing
TDP-43 dysfunction that mediates C9-related neurodegen-
eration, with NCT and NPC deﬁcits occurring later during
disease progression.
In our early onset models of disease, we observed speciﬁc
KPNA pathology but found no evidence for alterations of
other NCT or NPC components such as RanGAP, RCC1
and NPC proteins such as MAB414 and Nup50. These
ﬁndings are in agreement with a recent study that did not
ﬁnd any evidence for RanGap, lamin B1 and importin b1
pathology in C9ALS cases in which poly-GR pathology
was associated with site of disease and TDP-43 pathology
(Saberi et al., 2018). We observed a comparable phenotype
with targeted cytoplasmic accumulation of Drosophila
TDP-43, which caused KPNA4 pathology in the absence
of NPC pathology (Fig. 3E). Together these data suggest
that both poly-GR and TDP-43 dysfunction act through
similar, very speciﬁc KPNA pathology, but not other
NCT or NPC defects, to cause onset of disease. Since tar-
geted expression of poly-GR64 led to rapid accumulation
of cytosolic TDP-43 (Fig. 2B), the most parsimonious ex-
planation for these phenotypes are DPR-triggered TDP-43
pathology cause KPNA dysfunction and in turn neurode-
generation. In support of this notion, we observed accumu-
lating cytosolic TBPH not only enhanced DPR production
but also toxicity in our models of C9ALS/FTD.
This pathogenic cascade (Fig. 6C) suggests that add-
itional NCT and NPC defects are later events in the pro-
gression of disease, a notion consistent with our
Figure 6 KPNA4, phospho-TDP and sense DPR pathology in sporadic FTD-TDP and C9ALS/FTD human frontal cortex.
(A) KPNA4 immunolabelling in frontal cortex control cases reveals uniform neuronal distribution in both nucleus and cytoplasm (top row);
immunolabelled phospho-TDP-43 inclusions are detectable in both sporadic FTD-TDP (middle row) and C9ALS/FTD (bottom row). Note that in
both sporadic FTD-TDP and C9ALS/FTD, but not in controls, immunolabelling reveals nuclear depletion and cytoplasmic accumulation of KPNA4
that overlaps with accumulated phospho-TDP-43 (pTDP-43; arrowheads). (B) Similarly, in C9ALS/FTD frontal cortex sections, poly-GA, poly-GP
and poly-GR inclusions all overlap with clustered cytoplasmic KPNA4 immunolabelling adjacent to nuclear depletion (arrows). (C) Proposed
mechanism underlying disease formation and progression in C9ALS/FTD. Accumulation of G4C2-derived dipeptide repeat protein causes
cytoplasmic mislocalization and accumulation of TDP-43, which in turn leads to nuclear depletion of KPNAs and a vicious cycle of TDP-43 and
KPNA dysfunction that together with subsequent further deficits in nucleocytoplasmic transport and the nuclear pore complex, results in
neurodegeneration. Scale bars = 10mm.
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experimental ﬁndings but also with pathological evidence.
Thus, we observed KPNA4 pathology in sporadic FTD-
TDP cases and C9ALS/FTD human brain that correlated
either with phosphorylated (p)TDP-43 or sense DPR path-
ology, respectively. Notably, in both C9ALS/FTD and
FTD-TDP cases we also observed frequent KPNA4 path-
ology without pTDP-43 inclusions, and in C9ALS/FTD
cases, KPNA4 pathology without sense DPR inclusions
(Fig. 6A and B). These data suggest, rather than aggregate
formation, it is the cytoplasmic accumulation of soluble
DPRs and TDP-43, likely as toxic soluble oligomers, that
interferes with KPNA function. Consistent with suchlike
pathogenic mechanism, we found targeted expression of
accumulating cytosolic, but not aggregating TDP-43,
caused KPNA pathology and neurodegeneration (Fig. 3E
and Supplementary Fig. 7). These ﬁndings are consistent
with neuropathological studies suggesting that the site of
poly-GR toxicity is in the cytoplasm where it overlaps with
TDP-43 pathology, rather than the nucleus (Saberi et al.,
2018). Indeed, we found targeted poly-GR expression ini-
tially accumulated in the cytoplasm, which correlated with
onset of TDP-43 and KPNA pathology, rather than its sub-
sequent inclusion formation (Supplementary Fig. 5).
Taken together our ﬁndings establish DPR accumulation
as a cause of TDP-43 proteinopathy and suggest a vicious
feedback cycle for excess cytosolic TDP-43 by which
enhanced DPR levels enhance KPNA dysfunction and
TDP-43 mislocalization, thereby becoming self-sufﬁcient
of the initiating trigger. Unlike G4C2 RNA foci and the
vast majority of DPR inclusions (Mackenzie et al., 2015;
Mann, 2015; Scaber and Talbot, 2016; Saberi et al., 2018),
this pathogenic cascade accords well with distribution of
TDP-43 pathology, clinical phenotype and pattern of neu-
rodegeneration, and identiﬁes cytosolic accumulation of
non-aggregated TDP-43 as a major culprit of C9orf72-
related neurodegeneration.
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